Acetaminophen And Codeine Phosphate
NDC Package 61502-903-06

View Billable Units, 11-Digit Conversion Format, and RxNorm mappings
Table of Contents
    1. Package Information
    2. Other Packages
    3. Frequently Asked Questions

Package Information

This product is EXCLUDED from the official NDC directory because the listing data was inactivated by the FDA.

Acetaminophen And Codeine Phosphate is codeine-containing products are contraindicated for postoperative pain management in children who have undergone tonsillectomy and/or adenoidectomy. Marketed by Epm Packaging Inc, this product is identified by NDC 61502-903 and is authorized under FDA application ANDA088627.

Identification & Billing

NDC Package Code
61502-903-06
Package Description
6 TABLET in 1 BOTTLE
Product Code
61502-903
11-Digit Billing Format
61502090306
RxNorm Crosswalk
  • RxCUI: 993781 - codeine phosphate 30 MG / acetaminophen 300 MG Oral Tablet
  • RxCUI: 993781 - acetaminophen 300 MG / codeine phosphate 30 MG Oral Tablet
  • RxCUI: 993781 - APAP 300 MG / codeine phosphate 30 MG Oral Tablet

Clinical Specifications

Proprietary Name
Acetaminophen And Codeine Phosphate
Dosage Form
-
Usage Information
Codeine-containing products are contraindicated for postoperative pain management in children who have undergone tonsillectomy and/or adenoidectomy. This product should not be administered to patients who have previously exhibited hypersensitivity to codeine or acetaminophen.

Regulatory & Marketing

Labeler Name
Epm Packaging Inc
FDA Application #
ANDA088627
Marketing Category
ANDA - A product marketed under an approved Abbreviated New Drug Application.
Start Marketing Date
01-27-2016
Listing Expiration
12-31-2019
Exclude Flag
I
Sample Package
No

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Other Available Packages

The following commercial packages are registered under the same Product NDC (61502-903). Click a package code to view its specific billing and regulatory data.

61502-903-10
10 TABLET in 1 BOTTLE
61502-903-15
15 TABLET in 1 BOTTLE
61502-903-20
20 TABLET in 1 BOTTLE
61502-903-30
30 TABLET in 1 BOTTLE
61502-903-96
100 TABLET in 1 BOTTLE
61502-903-97
500 TABLET in 1 BOTTLE

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 61502-903-06 identifies a specific commercial package of 6 tablet in 1 bottle of Acetaminophen And Codeine Phosphate, labeled by Epm Packaging Inc. This is formulated for use and contains as the active substance.

Is this product currently listed with the FDA?

This product code is currently listed as inactive or excluded from the primary directory. It was introduced to the market by Epm Packaging Inc on January 27, 2016. The current certification is valid through December 31, 2019.

How is this Epm Packaging Inc product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 61502090306. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (5-3-2)
61502-903-06
11-Digit CMS (5-4-2)
61502-0903-06

Note: The zero is added to the Product segment to maintain the 5-4-2 structure.